Reliability and validity of a new sexual function questionnaire (Nagoya Sexual Function Questionnaire) for schizophrenic patients taking antipsychotics

Human Psychopharmacology

Volumn 26, Issue 4-5, 2011, Pages 300-306

  Kikuchi, Tsutomu ^a,b   Iwamoto, Kunihiro ^a   Sasada, Kazumi ^a   Aleksic, Branko ^a   Yoshida, Keizo ^a,c   Ozaki, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Matsuzaki Hospital   (Japan)

^c DENSO CORPORATION   (Japan)

Author keywords

antipsychotic agents; rating scale; schizophrenia; sexual dysfunction; validation

Indexed keywords

RISPERIDONE;

ADOLESCENT; ADULT; ARTICLE; CRONBACH ALPHA COEFFICIENT; DISCRIMINANT VALIDITY; EPWORTH SLEEPINESS SCALE; FEMALE; GALACTORRHEA; GYNECOMASTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NAGOYA SEXUAL FUNCTION QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCHIZOPHRENIA; SEXUAL FUNCTION; TEST RETEST RELIABILITY; UDVALG FOR KLINISKE UNDERSOGEKSER SIDE EFFECT RATING SCALE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GALACTORRHEA; GYNECOMASTIA; HUMANS; JAPAN; MALE; MENSTRUATION DISTURBANCES; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 79960839495     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1205     Document Type: Article

References (31)

1. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A,. 1995. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 56 (4): 131-141.
2. Clayton AH, Elizabeth L, McGarvey ED, Clavet GJ,. 1997. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 33 (4): 731-745. (Pubitemid 28128129)
3. Cutler AJ,. 2003. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28 (Suppl 1): 69-82. (Pubitemid 36015662)
4. Fakhoury WK, Wright D, Wallace M,. 2001. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 16 (3): 153-162. (Pubitemid 32402360)
5. Fujii A, Fukukori N, Sugawara N, et al,. 2010. Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 34 (2): 288-293.
6. Ghadirian AM, Chouinafd G, Annable L,. 1982. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 170 (8): 463-467. (Pubitemid 12051650)
7. Gopalakrishnan R, Jacob KS, Kuruvilla A, Vasantharaj B, John JK,. 2006. Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized double-blind, placebo-controlled, flexible-dose, two-way crossover trial. Am J Psychiatry 163 (3): 494-499. (Pubitemid 44469393)
8. Haddad PM, Wieck A,. 2004. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 64: 2291-2314. (Pubitemid 39388605)
9. Itoh H, Chiba S, Naoe J, Fuse A, Kawano K,. 2010. Considering utility of the Japanese version of UKU side effect rating scale. Psychiatr Neurol Jpn 106 (12): 1667.
10. Johns MW,. 1991. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (6): 540-545.
11. Kelly DL, Conley RR,. 2006. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology 31: 340-346. (Pubitemid 43261653)
12. Knegtering H, Boks M, Blijd C, Castelein S, van den Bosch RJ, Wiersma D,. 2006. A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Marital Ther 32: 315-326. (Pubitemid 43995227)
13. Knegtering R, Castelein S, Bous H, et al,. 2004. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol 24: 56-61. (Pubitemid 38139316)
14. Kotin J, Wilbert DE, Verburg D, Soldinger SM,. 1976. Thioridazine and sexual dysfunction. Am J Psychiatry 133 (1): 82-85.
15. Lingjaerde O, Ahkfors UG, Bech P, Dencker SJ, Elegen K,. 1987. The UKU side effect rating scale. a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334: 1-100. (Pubitemid 17115352)
16. McGahuey CA, Galenberg AJ, Laukes CA, et al,. 2000. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 26 (1): 25-40. (Pubitemid 30046590)
17. Montejo AL, Garcia M, Espada M, Rico-Villademoros F, Llorca G, Izquierdo JA,. 2000. Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish working group for the study of psychotropic-related sexual dysfunctions. Actas Esp Psiquiatr 28: 141-150.
18. Montejo AL, Majadas S, Rico-Villademoros F, et al,. 2010a. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med 7: 3404-3413.
19. Montejo AL, Riesgo Y, Luque J, et al,. 2010b. Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole. Actas Esp Psiquiatr 38 (1): 13-21.
20. Montejo AL, Rico-Villademoros F, Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. 2008a. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study. J Clin Psychopharmacol 28: 568-570.
21. Montejo AL, Rico-Villademoros F, Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. 2008b. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther 34: 227-239. (Pubitemid 351507750)
22. Montejo AL,. 2008c. Prolactin awareness: an essential consideration for physical health in schizophrenia. Eur Neuropsychopharmacol 18: S108-S114.
23. Montejo Gonzalez AL, Rico-Villademoros F, Tafalla M, Majadas S, Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. 2005. A 6-month prospective observational study on the effects of quetiapine on sexual functioning. J Clin Psychopharmacol 25: 533-538. (Pubitemid 41669044)
24. Moreira, Jr ED, Brock G, Glasser D, Gingell C,. 2006. Sexual activity and prevalence of sexual problems, and associated help-seeking patterns in men and women aged 40-80 years in Korea: data from the Global Study of Sexual Attitudes and Behaviors. J Sex Med 66 (3): 331-338.
25. Moreira, Jr ED, Hartmann U, Glasser D, Gimgell C, GSSAB Investigators 2005 Group. 2005. A population survey of sexual activity, sexual dysfunction and associated help-seeking behavior in middle-aged and older adults in Germany. Eur J Med Res 10 (10): 434-443. (Pubitemid 41614703)
26. Olfson M, Uttaro T, Carson WH, Tafesse E,. 2005. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry 66 (3): 331-338. (Pubitemid 40476756)
27. Segraves RT,. 1989. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 46 (3): 275-284. (Pubitemid 19078265)
28. Serretti A, Chiesa A,. 2011. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol 26 (3): 130-140.
29. Smith SM, O'Keane V, Murray R,. 2002. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181: 49-55. (Pubitemid 34717838)
30. Withersty DJ,. 1976. A model for continuing education. Am J Psychiatry 133: 573-575.
31. Wolfe SD, Menninger WW,. 1973. Fostering open communication about sexual concerns in a mental hospital. Hosp Community Psychiatry 24: 147-150.